ANGO logo

AngioDynamics, Inc. Stock Price

NasdaqGS:ANGO Community·US$463.9m Market Cap
  • 3 Narratives written by author
  • 0 Comments on narratives written by author
  • 9 Fair Values set on narratives written by author

ANGO Share Price Performance

US$11.05
5.17 (87.93%)
54.0% undervalued intrinsic discount
US$24.00
Fair Value
US$11.05
5.17 (87.93%)
54.0% undervalued intrinsic discount
US$24.00
Fair Value
Price US$11.05
AnalystHighTarget US$24.00
AnalystConsensusTarget US$18.25
AnalystLowTarget US$16.00

ANGO Community Narratives

AnalystHighTarget·
Fair Value US$24 54.0% undervalued intrinsic discount

AlphaVac And NanoKnife Will Transform Global Minimally Invasive Care

0users have liked this narrative
0users have commented on this narrative
0users have followed this narrative
AnalystConsensusTarget·
Fair Value US$18.25 39.5% undervalued intrinsic discount

Rising Demand For Minimally Invasive Care Will Expand Med Tech

0users have liked this narrative
0users have commented on this narrative
7users have followed this narrative
AnalystLowTarget·
Fair Value US$16 30.9% undervalued intrinsic discount

Rising Tariffs Will Pressure Margins But Modest Recovery Will Follow

0users have liked this narrative
0users have commented on this narrative
1users have followed this narrative

Recent ANGO News & Updates

We Think AngioDynamics (NASDAQ:ANGO) Can Afford To Drive Business Growth

Oct 03
We Think AngioDynamics (NASDAQ:ANGO) Can Afford To Drive Business Growth

AngioDynamics: Discounted Sales Multiple With Real Growth Engines

Oct 02

Revenues Working Against AngioDynamics, Inc.'s (NASDAQ:ANGO) Share Price

Aug 26
Revenues Working Against AngioDynamics, Inc.'s (NASDAQ:ANGO) Share Price
User avatar

FDA Approval And International Expansion Will Redefine Healthcare Delivery

Growth in proprietary therapies and expanding adoption of key platforms are driving improved margins, higher recurring revenues, and long-term earnings visibility.

AngioDynamics, Inc. Key Details

US$300.7m

Revenue

US$137.9m

Cost of Revenue

US$162.8m

Gross Profit

US$194.9m

Other Expenses

-US$32.1m

Earnings

Last Reported Earnings
Aug 31, 2025
Next Reporting Earnings
n/a
Earnings per share (EPS)
-0.78
Gross Margin
54.15%
Net Profit Margin
-10.67%
Debt/Equity Ratio
3.4%

AngioDynamics, Inc. Competitors

 
 
 
 
 
 
 
 
 
 
 
 

Snowflake Analysis

Flawless balance sheet with moderate growth potential.

0 Risks
1 Reward

About ANGO

Founded
1988
Employees
675
CEO
James Clemmer
WebsiteView website
www.angiodynamics.com

AngioDynamics, Inc., a medical technology company, designs, manufactures, and sells medical, surgical, and diagnostic devices for the use in treating peripheral vascular disease, and oncology and surgical settings in the United States and internationally. It offers Auryon Atherectomy system that delivers an optimized wavelength and short pulse width to remove lesions while preserving vessel wall endothelium. The company’s thrombus management portfolio includes AlphaVac mechanical thrombectomy system, an emergent mechanical aspiration device that eliminates the need for perfusionist support; thrombolytic catheters that are used to deliver thrombolytic agents, which are drugs to dissolve blood clots in hemodialysis access grafts, arteries, veins, and surgical bypass grafts; and AngioVac venous drainage cannula and extracorporeal circuit for use in extracorporeal circulatory support procedures for periods of up to six hours, as well as with other manufacturers’ off-the-shelf pump, filter, and reinfusion cannula facilitate venous drainage. It also offers NanoKnife IRE Ablation System, an alternative to traditional thermal ablation for the surgical ablation of soft tissue; and peripheral products, which includes angiographic catheters, diagnostic and interventional guidewires, and coaxial micro-introducer kits for use in peripheral diagnostic and interventional procedures. In addition, the company provides abscession drainage catheters for multi-purpose/general, nephrostomy, and biliary drainage; micro-access kits offer interventional physicians a smaller introducer system for minimally invasive procedures; VenaCure EVLT system that are used in endovascular laser procedures to treat superficial venous disease; and Solero Microwave Tissue Ablation System includes solero microwave generator and the solero MW applicators. AngioDynamics, Inc. was founded in 1988 and is headquartered in Latham, New York.

Market Insight

Rare earths may be a sliver of the global metals market, but they punch far above their weight. These obscure elements are the invisible wiring of modern life.
Continue reading

U.S. Market Performance

  • 7 Days: 0.4%
  • 3 Months: 7.8%
  • 1 Year: 17.8%
  • Year to Date: 14.7%
In the last week, the market has stayed flat, however the Healthcare sector stood out, gaining 3.7%. As for the longer term, the market has risen 18% in the past 12 months. Looking forward, earnings are forecast to grow by 15% annually. Market details ›